期刊文献+

中性粒细胞核右移幅度在紫杉醇化疗患者骨髓抑制监测中的意义探讨 被引量:3

Investigate the Neutrophil Nucleus Shifted to the Right Margin of the Significance of Monitoring in the Paclitaxel Chemotherapy in Patients with Bone Marrow Suppression
下载PDF
导出
摘要 目的探讨中性粒细胞核右移幅度在紫杉醇化疗患者骨髓抑制监测中的意义。方法 96例肿瘤患者紫杉醇化疗前后白细胞计数,同时做血涂片,瑞氏染液染色镜检。对中性粒细胞分类计数并计算百分率比,以有无中性粒细胞核右移及核右移幅度与白细胞计数变化幅度比较,判断中性粒细胞核右移幅度对骨髓抑制监测的意义。结果 96例紫杉醇化疗肿瘤患者中有94例出现了白细胞计数降低,70例肿瘤患者中性粒细胞核右移,而白细胞计数降低和中性粒细胞核右移并不完全同步。其中,26肿瘤患者未出现中性粒细胞核右移现象。结论外周血白细胞计数结合中性粒细胞分类计数核右移现象,可以更准确监测化疗肿瘤患者骨髓抑制程度,对患者的预后意义重大。 Objective Explore the significance of neutrophil nucleus shifted to the right margin in the bone marrow suppression monitoring of paclitaxel chemotherapy patients.Methods White blood cell count before and after 96 cases of tumor in patients with paclitaxel chemotherapy;at the same time do the blood smear,wright's dye staining.Classify and count the neutrophils and calculate the percentage ratio,comparing whether the right shift of the neutrophil nucleus exists and the magnitude of the right shift with the white blood cell count changes in amplitude,then we judge the significance.Results Among 96 cases of paclitaxel chemotherapy in cancer patients,the decrease of white blood cell count happens in 94 cases and the right shift of neutrophil nucleus happens in 70 cases while others not.However,the happening of the two phenomena are not completely synchronous.Conclusion Combining WBC count and the right shift phenomenon of neutrophil nucleus,we can monitor the bone marrow suppression level of tumor patients in chemotherapy more accurately,which is of great significance for the prognosis of patients.
作者 秦存恒
机构地区 枣庄市立医院
出处 《中国医药指南》 2012年第22期2-3,共2页 Guide of China Medicine
关键词 紫杉醇 中性粒细胞核右移 骨髓抑制 监测 Paclitaxel The right shift of Neutrophil nucleus Bone marrow suppression Monitoring
  • 相关文献

参考文献4

二级参考文献8

  • 1寇丽筠.临床检验基础学(第2版)[M].北京:人民卫生出版社,1999.41-42.
  • 2Blay JY,Chauvin F,Le Cesne A,et al.Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia[J].J Clin Oncol,1996,14(2):636-643.
  • 3Talcott JA,Siegel RD,Finberg R,et al.Risk assessment in cancer patients with fever and neutopenia:A prospective two-center validation of a prediction rule[J].J Clin Oncol,1992,10(2):316-322.
  • 4Michael Mac Manus,Kathleen Lamborn,Waqqar Khan,et al.Radiotherapy-associated neutropenia and thrombocytopenia:Analysis of risk factors and development of a predictive model[J].Blood,1997,89(7):2 303-2 310.
  • 5Coiffier B,Gisselbrecht C,Herbercht R,et al.LNH-84 regimen a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma[J].J Clin Oncol,1989,7(8):1 018-1 026.
  • 6Eric Voog,Jacques Bienvenu,Krzysztof Warzocha,et al.Factors That predict chemotherapy-induced myelosuppression in lymphoma patients:Role of the tumor necrosis factor ligand-receptor system[J].J Clin Oncol,2000,18(2):325-331.
  • 7Lyman GH,Lyman CH, Dale DC, et al. Risk models for the prediction of chemotherapy-induced neutropenia (CIN) and its consequences: a systematic review and classification(abstract 5 443)[J]. Blood,2001,98:413.
  • 8Crawford J,Dale DC,Lyman GH.Chemotherapy-induced neutropenia:risks,consequences, and new directions for its management[J].Cancer,2004,100(2):228-237.

共引文献25

同被引文献15

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部